Automated description from the Alliance of Genome Resources (Release 8.3.0)
Enables S100 protein binding activity and advanced glycation end-product binding activity. Involved in several processes, including cellular response to amyloid-beta; negative regulation of long-term synaptic potentiation; and positive regulation of cytokine production. Acts upstream of or within several processes, including induction of positive chemotaxis; negative regulation of connective tissue replacement involved in inflammatory response wound healing; and positive regulation of macromolecule metabolic process. Located in extracellular region; nucleus; and plasma membrane. Is expressed in several structures, including alimentary system; brain; genitourinary system; hemolymphoid system gland; and lung. Human ortholog(s) of this gene implicated in several diseases, including cardiovascular system disease (multiple); cystic fibrosis; diabetes mellitus (multiple); kidney failure (multiple); and lupus nephritis. Orthologous to human AGER (advanced glycosylation end-product specific receptor).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.